RxDoctor Payments Data

Megan Pflum, NP

Primary Care · Cincinnati, OHNPI 1184492456

Payments from drug & device makers

$1,251in general payments, 2019–2025

Across 79 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$411
  • AbbVie$189
  • Lilly USA, LLC$174
  • Exact Sciences$132
  • Bayer$61
  • Pfizer$55
  • plus $230 from 9 others

What the payments were for

  • Food & beverage$1,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,251 in reported general payments places this provider in the 75th percentile of 321 primary care providers in Ohio.

See all primary care providers in Ohio

Medicare billing

Part B allowed, 2024
$26,620
Medicare patients
160
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$87,882
OzempicSemaglutide47$48,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$34,203
JardianceEmpagliflozin18$29,214
FarxigaDapagliflozin Propanediol25$28,686
XareltoRivaroxaban24$20,957
TrulicityDulaglutide17$19,085
MyrbetriqMirabegron11$10,152
Breo ElliptaFluticasone/Vilanterol13$8,558
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$8,376
Testosterone12$4,231
Atorvastatin Calcium334$2,863
Gabapentin172$2,453
Levothyroxine Sodium206$2,248
Metoprolol Succinate137$1,775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$87,88286 claims
Novo NordiskOzempic$411$48,70847 claims
GSKTrelegy Ellipta, Breo Ellipta$14$42,76163 claims
Boehringer IngelheimJardiance$15$29,21418 claims
AstraZenecaFarxiga$44$28,68625 claims
Lilly USA, LLCTrulicity$174$19,08517 claims
AbbVieSynthroid$189$57135 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 321 primary care providers in Ohio.

Other primary care in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →